DMK Pharmaceuticals Corp
OTC:DMKPQ
DMK Pharmaceuticals Corp
OTC:DMKPQ
Price:
0.0001
USD
Market Closed
Market Cap:
$10
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
DMK Pharmaceuticals Corp
OTC:DMKPQ
|
US |
|
K
|
Komputronik SA w restrukturyzacji
WSE:KOM
|
PL |
Balance Sheet
Balance Sheet Decomposition
DMK Pharmaceuticals Corp
DMK Pharmaceuticals Corp
Balance Sheet Decomposition is not available for
DMK Pharmaceuticals Corp
DMK Pharmaceuticals Corp
Balance Sheet
DMK Pharmaceuticals Corp
DMK Pharmaceuticals Corp
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
4
|
4
|
4
|
17
|
19
|
9
|
7
|
23
|
1
|
|
| Cash Equivalents |
4
|
4
|
4
|
17
|
19
|
9
|
7
|
23
|
1
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
1
|
2
|
1
|
6
|
1
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
|
| Inventory |
0
|
0
|
1
|
2
|
3
|
2
|
3
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
2
|
1
|
1
|
6
|
6
|
|
| Total Current Assets |
4
|
4
|
7
|
21
|
26
|
14
|
13
|
35
|
9
|
|
| PP&E Net |
0
|
0
|
5
|
7
|
10
|
14
|
11
|
3
|
2
|
|
| PP&E Gross |
0
|
0
|
5
|
7
|
10
|
14
|
11
|
3
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
2
|
2
|
4
|
3
|
5
|
|
| Intangible Assets |
9
|
8
|
18
|
16
|
13
|
11
|
6
|
0
|
0
|
|
| Goodwill |
0
|
0
|
8
|
8
|
8
|
8
|
1
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
8
|
8
|
8
|
8
|
1
|
0
|
0
|
|
| Total Assets |
13
N/A
|
12
-7%
|
38
+213%
|
51
+36%
|
58
+14%
|
48
-18%
|
31
-35%
|
38
+24%
|
11
-71%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
1
|
2
|
3
|
4
|
4
|
3
|
4
|
8
|
|
| Accrued Liabilities |
1
|
1
|
2
|
3
|
4
|
3
|
12
|
6
|
2
|
|
| Short-Term Debt |
0
|
0
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
2
|
4
|
0
|
0
|
|
| Other Current Liabilities |
2
|
2
|
0
|
0
|
1
|
0
|
0
|
2
|
1
|
|
| Total Current Liabilities |
3
|
3
|
9
|
9
|
12
|
9
|
20
|
11
|
11
|
|
| Long-Term Debt |
0
|
0
|
3
|
3
|
0
|
0
|
1
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
5
|
6
|
1
|
0
|
|
| Total Liabilities |
3
N/A
|
3
-19%
|
13
+355%
|
12
-5%
|
12
-2%
|
15
+27%
|
27
+84%
|
12
-55%
|
12
-7%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
55
|
69
|
88
|
114
|
153
|
181
|
230
|
278
|
305
|
|
| Additional Paid In Capital |
65
|
78
|
114
|
154
|
200
|
214
|
233
|
304
|
304
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
10
N/A
|
9
-2%
|
25
+172%
|
40
+56%
|
47
+18%
|
33
-29%
|
4
-89%
|
26
+639%
|
1
N/A
|
|
| Total Liabilities & Equity |
13
N/A
|
12
-7%
|
38
+213%
|
51
+36%
|
58
+14%
|
48
-18%
|
31
-35%
|
38
+24%
|
11
-71%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| Preferred Shares Outstanding |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
